Annexon, Inc.
ANNXNASDAQHealthcare● Active
$5.37
+$0.08(+1.51%)
Market Cap$642225424
P/E Ratio—
52W High$7.18
52W Low$1.85
Annexon, Inc. (ANNX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ANNX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.23
Est. -$0.30 · +23.3%
Revenue
—
Est. $0.01B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
ANNX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.24 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.30 | -$0.23 | +23.3% | — | $0.01B | — |
| ▲ Q1 FY2026 | Mar 30, 2026 | -$0.32 | -$0.28 | +12.5% | — | $0.00B | — |
| ▼ Q4 FY2025 | Nov 10, 2025 | -$0.34 | -$0.37 | -8.8% | — | — | — |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.36 | -$0.34 | +5.6% | — | — | — |
| ▼ Q2 FY2025 | May 12, 2025 | -$0.30 | -$0.37 | -23.3% | — | — | — |
| ▼ Q1 FY2025 | Mar 3, 2025 | -$0.28 | -$0.33 | -17.9% | — | — | — |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$0.26 | -$0.25 | +3.9% | — | — | — |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.24
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.23
EPS Est.
-$0.30
EPS Surpr.
+23.3%
Revenue
—
Q1 FY2026
Mar 30, 2026Beat
EPS Actual
-$0.28
EPS Est.
-$0.32
EPS Surpr.
+12.5%
Revenue
—
Q4 FY2025
Nov 10, 2025Miss
EPS Actual
-$0.37
EPS Est.
-$0.34
EPS Surpr.
-8.8%
Revenue
—
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.34
EPS Est.
-$0.36
EPS Surpr.
+5.6%
Revenue
—
Q2 FY2025
May 12, 2025Miss
EPS Actual
-$0.37
EPS Est.
-$0.30
EPS Surpr.
-23.3%
Revenue
—
Q1 FY2025
Mar 3, 2025Miss
EPS Actual
-$0.33
EPS Est.
-$0.28
EPS Surpr.
-17.9%
Revenue
—
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$0.25
EPS Est.
-$0.26
EPS Surpr.
+3.9%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.20 | $-0.20 | $-0.20 | 2 |
| Q3 FY2027 | $-0.28 | $-0.28 | $-0.28 | 1 |
| Q2 FY2027 | $-0.26 | $-0.26 | $-0.26 | 1 |
| Q1 FY2027 | $-0.23 | $-0.23 | $-0.23 | 2 |
| Q4 FY2026 | $-0.24 | $-0.24 | $-0.24 | 2 |
| Q3 FY2026 | $-0.27 | $-0.25 | $-0.24 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +23.3% | $5.70 | $5.52 | -3.16% |
| ▲ Q1 FY2026 | Mar 30, 2026 | +12.5% | $5.00 | $4.96 | -0.80% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -8.8% | $2.88 | $2.98 | +3.47% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +5.6% | $2.60 | $2.38 | -8.46% |
| ▼ Q2 FY2025 | May 12, 2025 | -23.3% | $1.60 | $1.77 | +10.62% |
| ▼ Q1 FY2025 | Mar 3, 2025 | -17.9% | $2.64 | $2.39 | -9.47% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +3.9% | $6.55 | $6.33 | -3.36% |
| ▲ Q3 FY2024 | Aug 12, 2024 | +0.0% | $5.48 | $5.61 | +2.37% |
Q2 FY2026-3.16%
Report Date
May 7, 2026
EPS Beat/Miss
+23.3%
Price Before
$5.70
Price After
$5.52
Q1 FY2026-0.80%
Report Date
Mar 30, 2026
EPS Beat/Miss
+12.5%
Price Before
$5.00
Price After
$4.96
Q4 FY2025+3.47%
Report Date
Nov 10, 2025
EPS Beat/Miss
-8.8%
Price Before
$2.88
Price After
$2.98
Q3 FY2025-8.46%
Report Date
Aug 14, 2025
EPS Beat/Miss
+5.6%
Price Before
$2.60
Price After
$2.38
Q2 FY2025+10.62%
Report Date
May 12, 2025
EPS Beat/Miss
-23.3%
Price Before
$1.60
Price After
$1.77
Q1 FY2025-9.47%
Report Date
Mar 3, 2025
EPS Beat/Miss
-17.9%
Price Before
$2.64
Price After
$2.39
Q4 FY2024-3.36%
Report Date
Nov 14, 2024
EPS Beat/Miss
+3.9%
Price Before
$6.55
Price After
$6.33
Q3 FY2024+2.37%
Report Date
Aug 12, 2024
EPS Beat/Miss
+0.0%
Price Before
$5.48
Price After
$5.61
Avg Beat Reaction-2.68%
Avg Miss Reaction+1.54%
Beat Rate5 / 8 quarters
Largest Move+10.62% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ANNX ends December
Annexon, Inc. (ANNX) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.23 — beating the analyst consensus of $-0.30 by +23.3%. ANNX has beaten EPS estimates for 2 consecutive quarters. The next ANNX earnings date is expected around September 1, 2026.
Each quarter, investors track ANNX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ANNX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ANNX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ANNX earnings · 5 questionsAnnexon, Inc.'s next earnings report is expected around September 1, 2026. ANNX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ANNX historically reports after market close (AMC).
ANNX earnings datewhen is ANNX earningsANNX next earnings datewhen does ANNX report earningsANNX earnings calendar
▸ Source: FMP · Annexon, Inc. SEC filings · US GAAP · Annexon, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026